CN1443186A - 用于糖尿病治疗的噻唑烷二酮盐 - Google Patents

用于糖尿病治疗的噻唑烷二酮盐 Download PDF

Info

Publication number
CN1443186A
CN1443186A CN01813190A CN01813190A CN1443186A CN 1443186 A CN1443186 A CN 1443186A CN 01813190 A CN01813190 A CN 01813190A CN 01813190 A CN01813190 A CN 01813190A CN 1443186 A CN1443186 A CN 1443186A
Authority
CN
China
Prior art keywords
solvate
compound
hydrobromide
thiazolidine
pyridyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN01813190A
Other languages
English (en)
Chinese (zh)
Inventor
安德鲁·S·克雷格
蒂姆·C·T·霍
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of CN1443186A publication Critical patent/CN1443186A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CN01813190A 2000-06-08 2001-06-08 用于糖尿病治疗的噻唑烷二酮盐 Pending CN1443186A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0014006.1 2000-06-08
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
CN1443186A true CN1443186A (zh) 2003-09-17

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
CN01813190A Pending CN1443186A (zh) 2000-06-08 2001-06-08 用于糖尿病治疗的噻唑烷二酮盐

Country Status (23)

Country Link
EP (1) EP1296980A1 (cs)
JP (1) JP2003535862A (cs)
KR (1) KR20030007918A (cs)
CN (1) CN1443186A (cs)
AP (1) AP2002002673A0 (cs)
AU (1) AU2001264078A1 (cs)
BG (1) BG107357A (cs)
BR (1) BR0111536A (cs)
CA (1) CA2411065A1 (cs)
CZ (1) CZ20023966A3 (cs)
DZ (1) DZ3382A1 (cs)
EA (1) EA200300005A1 (cs)
GB (1) GB0014006D0 (cs)
HU (1) HUP0301137A3 (cs)
IL (1) IL153279A0 (cs)
MA (1) MA25753A1 (cs)
MX (1) MXPA02012100A (cs)
NO (1) NO20025883L (cs)
OA (1) OA12284A (cs)
PL (1) PL360592A1 (cs)
SK (1) SK17142002A3 (cs)
WO (1) WO2001094344A1 (cs)
ZA (1) ZA200209954B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (de) * 2005-07-22 2007-02-01 Ratiopharm Gmbh Neue Salze von Rosiglitazon
EP2016076A2 (en) * 2007-01-22 2009-01-21 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (de) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Verfahren zur Herstellung eines Benzimidazolderivats
WO2010021745A2 (en) * 2008-08-21 2010-02-25 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
BG107357A (bg) 2003-08-29
PL360592A1 (en) 2004-09-20
CA2411065A1 (en) 2001-12-13
AU2001264078A1 (en) 2001-12-17
CZ20023966A3 (cs) 2003-04-16
BR0111536A (pt) 2003-07-01
JP2003535862A (ja) 2003-12-02
GB0014006D0 (en) 2000-08-02
NO20025883D0 (no) 2002-12-06
EA200300005A1 (ru) 2003-04-24
DZ3382A1 (fr) 2001-12-13
MXPA02012100A (es) 2003-04-25
AP2002002673A0 (en) 2002-12-31
KR20030007918A (ko) 2003-01-23
MA25753A1 (fr) 2003-04-01
ZA200209954B (en) 2003-10-10
IL153279A0 (en) 2003-07-06
EP1296980A1 (en) 2003-04-02
WO2001094344A1 (en) 2001-12-13
HUP0301137A2 (hu) 2003-08-28
NO20025883L (no) 2003-02-03
HUP0301137A3 (en) 2005-04-28
OA12284A (en) 2003-11-10
SK17142002A3 (sk) 2003-10-07

Similar Documents

Publication Publication Date Title
CN1208335C (zh) 噻唑烷二酮衍生物及其作为抗糖尿病药的用途
CN1167702C (zh) 5-[4-[2-n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的多晶型物
CN1358184A (zh) 新药物
CN1285831A (zh) 取代的噻唑烷二酮衍生物,其制备过程及其药学用途
CN1281453A (zh) 作为药物的5－[4－[2－(n－甲基－n－(2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮马来酸盐的水合物
CN1152878C (zh) 噻唑烷二酮衍生物及其作为抗糖尿病药的用途
JP2009161544A (ja) チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用
CN1281454A (zh) 5－[4－[2－(n－甲基－n－(2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮马来酸盐的水合物
CN1430959A (zh) 含有5－[4－[2－（n－甲基－n－2－吡啶基）氨基）乙氧基]苄基]噻唑烷－2，4－二酮的组合物
CN1443186A (zh) 用于糖尿病治疗的噻唑烷二酮盐
CN1310912C (zh) 5－[4－[2－(n－甲基－n－(2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮甲磺酸盐
CN1239501C (zh) 噻唑烷二酮衍生物以及其作为抗糖尿病药物的应用
CN1366520A (zh) 新型医药
CN1612874A (zh) 罗格列酮乙二磺酸盐和它们作为抗糖尿病药物的用途
BG107606A (bg) Тартаратни соли на тиазолидиндионово производно
CN100415741C (zh) 一种噻唑烷二酮衍生物以及其制备抗糖尿病药的应用
CN100345846C (zh) 5－[4－[2－(n－甲基－n－(2－吡啶基)氨基)乙氧基]苄基]噻唑烷－2,4－二酮的钠盐
CN1458930A (zh) 噻唑烷二酮衍生物的酒石酸盐
CN1455778A (zh) 四氢噻唑二酮衍生物的酒石酸盐
CN1455777A (zh) 四氢噻唑二酮衍生物的酒石酸盐
CN1620453A (zh) 噻唑烷二酮衍生物及其作为抗糖尿病药的用途
CN1471531A (zh) 噻唑烷酮(thiazolidinone)硝酸盐
CN1443185A (zh) 药用的5－(4－(2－(n－甲基－n－(2－吡啶基)氨基)乙氧基)苄基)噻唑烷－2,4－二酮氢碘化物
CN1535271A (zh) 5-[4-[2-[n-甲基-n-(2-吡啶基)氨基]乙氧基]苄基]噻唑烷-2,4-二酮马来酸盐的新多晶型形态及其制备方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication